SOURCE: Hard to Treat Diseases, Inc.

March 17, 2006 11:08 ET

Hard To Treat Diseases, Incorporated Announces: Motion for Summary Judgment Filed in Oklahoma

DELRAY BEACH, FL -- (MARKET WIRE) -- March 17, 2006 -- Hard To Treat Diseases, Incorporated (HTTD) (OTC: HTDS) announces that a Motion For Summary Judgment was filed yesterday on its behalf in the District Court of Oklahoma County.

The Motion makes the following facts abundantly clear: 1) HTTD is the lawful owner of the Tubercin substance in its possession and testing results performed on behalf of HTTD, 2) Shinn and his affiliated companies are keenly aware that they have no legal claim or rights to HTTD's Tubercin substance or testing results.

The Motion For Summary Judgment with exhibits will be posted on HTTD's website at www.htdsotc.com as soon as they are available.

HTTD's CEO Colm J. King states, "Shareholders will be kept informed on this matter and the progress of the Company's drug testing and related patents filed."

Cautionary Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard To Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Contact Information

  • CONTACT:
    Colm J. King
    CEO
    (561) 278-7856
    Hard to Treat Diseases, Incorporated
    www.htdsotc.com